| 1 |
2023 |
Xiaosong Wei, Beibei Wang, Zixin Wu, Xiaoming Yang, Yufeng Guo, Yang Yang, Zhiwei Fang, Chengzhi Yi, Liuhui Zhang, Xin Fan, Lirong Zhang, Dongkui Song. WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity, Cancer Letters. 2023; 556: 216058216058.
https://doi.org/10.1016/j.canlet.2023.216058 |
| 2 |
2023 |
Nagaraj Balan Selvaraj, Akey Krishna Swaroop, Esakkimuthukumar Mariappan, Jawahar Natarajan, Prabha Thangavelu, Jubie Selvaraj. Effect of Calcitriol in Inhibiting the Cancer Cell Growth and Promoting Apoptosis in
ErbB2-positive Breast Cancer Cells, Anti-Cancer Agents in Medicinal Chemistry. 2023; 23: 2056.
https://doi.org/10.2174/1871520623666230822100006 |
| 3 |
2023 |
Mateusz Wylaź, Anna Kaczmarska, Dawid Pajor, Matthew Hryniewicki, Dorota Gil, Joanna Dulińska-Litewka. Exploring the role of PI3K/AKT/mTOR inhibitors in hormone-related cancers: A focus on breast and prostate cancer, Biomedicine & Pharmacotherapy. 2023; 168: 115676115676.
https://doi.org/10.1016/j.biopha.2023.115676 |
| 4 |
2023 |
Lars van der Veen, Michael Schmitt, Marcel A. Deken, Michael Lahn. Non-Clinical Toxicology Evaluation of the Novel Non-ATP Competitive Oral PI3 Kinase Delta Inhibitor Roginolisib, International Journal of Toxicology. 2023; 42: 515.
https://doi.org/10.1177/10915818231200419 |
| 5 |
2022 |
Marzia Di Donato, Pia Giovannelli, Antimo Migliaccio, Antonio Bilancio. Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells, International Journal of Molecular Sciences. 2022; 23: 9008.
https://doi.org/10.3390/ijms23169008 |
| 6 |
2024 |
Xiaoyan Zhang, Fengyu Yang, Zhijian Huang, Xiaojun Liu, Gan Xia, Jieye Huang, Yang Yang, Junchen Li, Jin Huang, Yuxin Liu, Ti Zhou, Weiwei Qi, Guoquan Gao, Xia Yang. Macrophages Promote Subtype Conversion and Endocrine Resistance in Breast Cancer, Cancers. 2024; 16: 678.
https://doi.org/10.3390/cancers16030678 |
